233 related articles for article (PubMed ID: 22450890)
21. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H
J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015
[TBL] [Abstract][Full Text] [Related]
22. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
[TBL] [Abstract][Full Text] [Related]
23. Increased macrophage activation marker soluble CD163 is associated with graft dysfunction and metabolic derangements in renal transplant recipients.
El Aggan H; Mahmoud S; El Shair H; Elabd H
Biomed J; 2021 Dec; 44(6 Suppl 2):S179-S189. PubMed ID: 35300946
[TBL] [Abstract][Full Text] [Related]
24. Serum soluble CD163 predicts risk of type 2 diabetes in the general population.
Møller HJ; Frikke-Schmidt R; Moestrup SK; Nordestgaard BG; Tybjærg-Hansen A
Clin Chem; 2011 Feb; 57(2):291-7. PubMed ID: 21106861
[TBL] [Abstract][Full Text] [Related]
25. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
26. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
27. Soluble CD163.
Møller HJ
Scand J Clin Lab Invest; 2012 Feb; 72(1):1-13. PubMed ID: 22060747
[TBL] [Abstract][Full Text] [Related]
28. The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children.
Kazankov K; Møller HJ; Lange A; Birkebaek NH; Holland-Fischer P; Solvig J; Hørlyck A; Kristensen K; Rittig S; Handberg A; Vilstrup H; Grønbaek H
Pediatr Obes; 2015 Jun; 10(3):226-33. PubMed ID: 25073966
[TBL] [Abstract][Full Text] [Related]
29. Sitagliptin but not alpha glucosidase inhibitor reduced the serum soluble CD163, a marker for activated macrophage, in individuals with type 2 diabetes mellitus.
Hattori A; Takemoto M; Tokuyama H; Koshizaka M; Yokote K
Diabetes Res Clin Pract; 2017 Apr; 126():138-143. PubMed ID: 28237860
[TBL] [Abstract][Full Text] [Related]
30. Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients.
Kjærgaard AG; Rødgaard-Hansen S; Dige A; Krog J; Møller HJ; Tønnesen E
PLoS One; 2014; 9(3):e92331. PubMed ID: 24637679
[TBL] [Abstract][Full Text] [Related]
31. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
Gao J; Song L; Li D; Peng L; Ding H
Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
[TBL] [Abstract][Full Text] [Related]
32. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
Salinitri FD; Pinelli NR; Martin ET; Jaber LA
Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
[TBL] [Abstract][Full Text] [Related]
33. Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance.
Dereke J; Nilsson J; Nilsson C; Strevens H; Landin-Olsson M; Hillman M
PLoS One; 2019; 14(5):e0216728. PubMed ID: 31071174
[TBL] [Abstract][Full Text] [Related]
34. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
Knudsen TB; Ertner G; Petersen J; Møller HJ; Moestrup SK; Eugen-Olsen J; Kronborg G; Benfield T
J Infect Dis; 2016 Oct; 214(8):1198-204. PubMed ID: 27354366
[TBL] [Abstract][Full Text] [Related]
35. Levels of soluble CD163 and severity of malaria in children in Ghana.
Kusi KA; Gyan BA; Goka BQ; Dodoo D; Obeng-Adjei G; Troye-Blomberg M; Akanmori BD; Adjimani JP
Clin Vaccine Immunol; 2008 Sep; 15(9):1456-60. PubMed ID: 18632918
[TBL] [Abstract][Full Text] [Related]
36. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study).
Marques-Vidal P; Bastardot F; von Känel R; Paccaud F; Preisig M; Waeber G; Vollenweider P
Clin Endocrinol (Oxf); 2013 Feb; 78(2):232-41. PubMed ID: 22409372
[TBL] [Abstract][Full Text] [Related]
37. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.
Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I
Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052
[TBL] [Abstract][Full Text] [Related]
38. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
Kazankov K; Barrera F; Møller HJ; Bibby BM; Vilstrup H; George J; Grønbaek H
Hepatology; 2014 Aug; 60(2):521-30. PubMed ID: 24623375
[TBL] [Abstract][Full Text] [Related]
39. The association of high sCD163/sTWEAK ratio with cardiovascular disease in hemodialysis patients.
Rusu CC; Racasan S; Kacso IM; Ghervan L; Moldovan D; Potra A; Patiu IM; Bondor C; Caprioara MG
Int Urol Nephrol; 2015 Dec; 47(12):2023-30. PubMed ID: 26433887
[TBL] [Abstract][Full Text] [Related]
40. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
